The research, led by Priyaranjan Mandal and Kamesh R. Babu at UPES in Dehradun, India, together with colleagues Sourabh Behra and Aarika Kasliwal, set out to answer a question that has quietly emerged as worm labs have changed how they feed their animals. Increasingly, researchers studying metabolism, aging, and host-microbe interactions kill the food bacteria with paraformaldehyde, or PFA, before putting them on the plates. Dead bacteria cannot reproduce, which prevents the food source from metabolically confounding the experiment. But if the bacteria are never going to proliferate, the peptone that exists to support that proliferation loses its purpose, and it may instead serve as a nutrient source for contaminating organisms.

The team systematically compared conventional NGM with a peptone-free version, using PFA-killed OP50, the standard laboratory strain of E. coli, as the sole food source in both cases. The results were striking. On conventional plates, residual bacterial proliferation persisted despite the killing procedure, and fungal contamination appeared more readily. On plates lacking peptone, residual bacterial growth was completely prevented and fungal contamination was markedly reduced. The peptone, it turns out, had been acting as an unintended growth substrate, undermining the very experimental control that PFA-killed bacteria are meant to provide and destabilizing cultures over time.

A natural concern was that removing a protein-rich nutrient from the medium might starve the worms or alter their biology in subtle ways that would confound downstream measurements. The researchers therefore ran a battery of standard physiological assays. Worms raised on peptone-free medium grew at a normal rate, reproduced normally, produced embryos with normal viability, lived a normal lifespan, and navigated chemotactic gradients with intact behavioral precision. In other words, the core biological outputs that most worm experiments measure were unchanged. The animals could not tell the difference in any way that matters for standard phenotyping, even though the chemical composition of their environment had shifted substantially.

Some behaviors did change. Worms on the peptone-free diet showed reduced food preference and reduced pharyngeal pumping, the muscular swallowing motion that constitutes worm feeding. Because the bacteria were dead and non-proliferating, the animals were presumably responding to a thinner or less attractive bacterial lawn, one that no longer received nutritional supplementation from the underlying medium. This is a meaningful consideration for experiments focused specifically on feeding behavior, and the authors note that it is one of the trade-offs of the modified recipe. For studies of aging, stress biology, and metabolism, however, the preserved growth, fertility, lifespan, and chemotaxis suggest the change is physiologically benign in most respects.

Where the differences emerged most clearly was in the worms’ internal biochemistry. Animals cultured on peptone-free medium showed lower basal levels of intracellular reactive oxygen species, the chemically reactive molecules that accumulate as byproducts of metabolism and contribute to oxidative damage over time. They also accumulated less lipid. At the molecular level, these changes were accompanied by downregulation of genes involved in oxidative stress responses and in lipogenesis, the biochemical pathway that builds fatty acids. The pattern suggests that worms on the simplified diet experienced a milder baseline metabolic state, with less endogenous oxidant generation and less drive to store fat, rather than being forced into stress-response mode.

That biochemical shift translated into what the authors describe as enhanced physiological resilience. Worms grown on the peptone-free medium displayed greater locomotor activity than their conventionally raised counterparts, moving more vigorously across the agar surface. More remarkably, they survived significantly better under three different forms of imposed adversity: oxidative stress, ultraviolet radiation, and heat. The convergence of reduced baseline ROS, altered stress-gene expression, and improved resistance to multiple external stressors paints a coherent picture of animals in a more robust physiological condition, even though their gross development and reproduction appeared entirely normal.

The findings carry particular weight for the growing field of diet-aging research in worms, where the bacterial food source is now recognized as a major experimental variable. Studies in recent years have shown that different bacterial diets can alter fat storage, longevity trajectories, associative learning decline, and neuronal survival, and that the method used to kill the bacteria, whether by ultraviolet irradiation, heat, or chemical fixation, itself changes worm physiology. Against that backdrop, a medium change that reduces baseline oxidative stress and lipid accumulation while preserving lifespan is not a trivial technical footnote. It means that labs using PFA-killed bacteria on conventional NGM may be measuring worm biology through an unnecessary layer of medium-derived metabolic noise.

There are also practical advantages that extend beyond experimental cleanliness. Peptone is a variable, animal-derived reagent whose exact composition can differ between manufacturers and batches, introducing an uncontrolled source of plate-to-plate variation. Removing it simplifies the recipe, reduces cost, and eliminates a reagent that must be quality-controlled. The authors describe peptone-free NGM as a simple, inexpensive, and practical refinement of the conventional culture system, and the word refinement is chosen deliberately: the change does not create a new platform but tightens the reliability of one that has been in continuous use since Sydney Brenner established C. elegans as a genetic model organism in the 1970s.

For a model organism whose transparency, short lifespan, and genetic tractability have made it a workhorse of aging and disease research, small methodological improvements can ripple widely. The peptone-free protocol requires no special equipment, no genetic engineering, and no retraining; it is a subtraction rather than an addition. As labs that rely on metabolically inactivated bacteria adopt the modified medium, the study’s broader implication may prove to be about experimental reproducibility: the cleaner and more defined the culture environment, the more confidently researchers can attribute the biology they observe to their genes, drugs, and interventions of interest rather than to their plates.

Subject of Research: Effects of peptone-free nematode growth medium on culture stability and stress resilience in Caenorhabditis elegans

Article Title: Peptone-free nematode growth medium improves culture stability and physiological resilience in Caenorhabditis elegans

Article References: Mandal, P., Behra, S., Kasliwal, A., & Babu, K. R. (2026). Peptone-free nematode growth medium improves culture stability and physiological resilience in Caenorhabditis elegans. Biogerontology, 27(5), Article 169. https://doi.org/10.1007/s10522-026-10513-1

Image Credits: AI Generated

DOI: 10.1007/s10522-026-10513-1

Keywords: Caenorhabditis elegans, nematode growth medium, peptone, Escherichia coli OP50, paraformaldehyde, culture stability, reactive oxygen species, oxidative stress, lipid accumulation, lifespan, biogerontology, host-microbe interactions

RORα, short for retinoic acid receptor-related orphan receptor alpha, is a transcription factor that senses cholesterol levels and switches genes on or off in response. Genetic variants of the RORA gene have previously been associated with increased susceptibility to both the dry and neovascular forms of AMD in humans, and earlier work from the same group showed that RORα deficiency worsens laser-induced choroidal neovascularization in young mice. What remained unclear was exactly how the receptor influences the immune cells that swarm into the aging retina and whether its effects on fat metabolism and inflammation were two sides of the same coin. The new study set out to answer that question using two complementary mouse models: the spontaneous Staggerer mutant (Rora sg/sg), which lacks functional RORα throughout the body, and a myeloid-specific knockout (Rora fl/fl;LysMCre) in which the receptor is deleted only in macrophages and related immune cells.

The results were striking. As the Staggerer mice aged, they developed increasing numbers of abnormal whitish-yellow fundus lesions that resemble the drusen and deposits seen in human AMD patients, with more than a fivefold increase in lesion number by nine months of age. Retinal cross-sections revealed subretinal deposits, focal disruption of the retinal pigment epithelium, and sloughed RPE cells. Critically, the subretinal space of these mice, which in healthy eyes is normally kept free of immune cells by immunosuppressive factors secreted by the RPE, became crowded with CD11b- and IBA1-positive microglia and macrophages. The counts were more than double those of age-matched controls, and the accumulated immune cells were visibly bloated with neutral lipids, stained with a fluorescent lipid probe called LipidSpot 610. The number of these lipid-laden cells correlated with the density of fundus lesions, suggesting a causal relationship between immune cell fat overload and the visible pathology.

When the researchers induced choroidal neovascularization with laser photocoagulation in aged mice, the Staggerer animals fared far worse than controls. Their CNV lesions were significantly larger, surrounded by expanded zones of IBA1-positive macrophages and microglia, and far leakier on fluorescein angiography. While roughly 43 percent of lesions in wild-type aged mice showed only mild grade 1 hyperfluorescence and none reached the pathologically significant grade 2B, the RORα-deficient mice showed a much higher proportion of severely leaking lesions. Even outside the laser sites, the microglia of deficient mice displayed an activated, amoeboid morphology, with enlarged cell bodies, fewer branches, and shorter processes, the classic signature of inflammatory rather than surveillance-mode immune cells.

To prove that these effects stemmed from the immune cells themselves rather than some other tissue, the team turned to the myeloid-specific knockout. Deleting RORα only in the myeloid lineage reproduced the key findings: more fundus lesions at six, twelve, and beyond twelve months of age, larger lesion areas, increased subretinal accumulation of activated microglia, and elevated lipid droplet formation in immune cells of both young and aged animals. Laser-induced CNV lesions were larger in these mice as well, with 84 percent graded as leaky compared with 41 percent in floxed controls, and ex vivo choroidal explants from the knockout mice sprouted significantly more vessels, pointing to a pro-angiogenic shift driven by macrophages rather than by the vascular endothelium directly.

The mechanistic heart of the paper lies in what RORα does to PPARγ, a master regulator of fat uptake and storage. In RORα-deficient macrophages, retinas, and RPE/choroid tissue, Pparg mRNA and PPARγ protein were substantially upregulated, roughly doubling at the protein level. Chromatin immunoprecipitation experiments showed that RORα physically binds to a specific response element in the Pparg promoter, indicating that under normal conditions the receptor directly represses this lipogenic gene. When RORα is absent or pharmacologically inhibited with inverse agonists such as SR3335 and SR1001, PPARγ expression surges, lipid droplet formation increases roughly threefold, and macrophages take up more low-density lipoprotein. Exposure to 7-ketocholesterol, an oxidized cholesterol product that is a major component of drusen, further exaggerated lipid accumulation in the deficient cells, highlighting their heightened vulnerability to the very molecules that pile up in AMD eyes.

The lipid overload was not benign. RORα-deficient macrophages, retinas, and RPE/choroid samples showed elevated levels of the pro-inflammatory cytokines TNFα, IL-6, and IL-1β, along with reduced anti-inflammatory IL-10, and increased activation of NF-κB, the central inflammatory signaling pathway implicated in AMD. The deficient immune cells also lost expression of two migratory receptors, CX3CR1 and CD47, which are essential for macrophages and microglia to exit the subretinal space once their cleanup work is done. CD47 in particular is a known AMD risk factor that declines with age in humans. With these exit routes downregulated, the cells became trapped, proliferated more actively, migrated more aggressively in transwell assays, and produced more angiogenic factors including VEGF-A, VEGF-D, and angiopoietin-2. Conditioned medium from lipid-laden macrophages even stimulated the proliferation of human choroidal endothelial cells in culture, providing a direct functional link between macrophage fat overload and new blood vessel growth.

Perhaps most importantly for patients, the pathway proved druggable, at least in mice. When the researchers treated myeloid-specific knockout animals with T0070907, a selective PPARγ antagonist, before and during laser-induced CNV, lesion size shrank significantly, lipid droplet accumulation in retinal macrophages dropped markedly, and retinal expression of TNFα and IL-6 fell. This demonstrates that PPARγ acts as a key downstream effector of RORα signaling and that blocking it can partially reverse the damage caused by losing the receptor. In other words, the RORα–PPARγ axis offers a concrete therapeutic target: restoring RORα function or damping PPARγ activity could, in principle, restore lipid balance in retinal immune cells and cool the chronic inflammation that fuels neovascularization.

The findings arrive at a moment of growing translational momentum for RORα biology. A recent study showed that RORA-expressing gene therapy rescued retinal degeneration in a mouse model of Stargardt disease and dry AMD, and clinical trials evaluating RORA as a gene modifier therapy are currently underway for those conditions. The new work extends the receptor’s relevance to the wet, neovascular form of the disease and pinpoints the myeloid cell as the critical cellular mediator. There are caveats: the LysMCre system does not exclusively target microglia and shows incomplete recombination in that population, so the results reflect deletion in LysM-expressing myeloid cells broadly, and the human genetic association data for RORA and AMD risk have not been extensively updated by more recent studies. Still, the convergence of mouse genetics, pharmacology, chromatin biology, and human genetic association makes a compelling case that RORα sits at the junction of lipid metabolism and immune regulation in the aging retina.

What emerges is a coherent model of AMD pathogenesis in which a single nuclear receptor orchestrates an entire disease program. Under normal conditions, active RORα signaling keeps PPARγ in check, maintains lipid homeostasis in microglia and macrophages, supports the expression of migratory receptors that allow immune cells to leave the subretinal space, and restrains inflammatory cytokine production. When RORα is lost, whether through genetic variation, aging-related dysfunction, or the flood of oxidized cholesterol that characterizes the AMD eye, the system flips: PPARγ rises, immune cells gorge on lipids and become trapped, NF-κB-driven inflammation intensifies, and pro-angiogenic signals recruit the abnormal choroidal vessels that destroy central vision. If future therapies can reengage this axis in human patients, they may finally address one of the deepest roots of a disease that currently can only be managed, not prevented, at its immunometabolic source.

Subject of Research: Role of the nuclear receptor RORα in myeloid cell lipid metabolism, subretinal inflammation, and choroidal neovascularization in age-related macular degeneration

Article Title: Myeloid deficiency of RORα exacerbates lipid dysregulation and laser-induced choroidal neovascularization

Article References: Kushwah, N., Liu, C.-H., Bora, K., Maurya, M., Pavlovich, M. C., Fu, Z., Kamenecka, T. M., Sun, Y., Solt, L. A., & Chen, J. (2026). Myeloid deficiency of RORα exacerbates lipid dysregulation and laser-induced choroidal neovascularization. Angiogenesis, 29(4), Article 73. https://doi.org/10.1007/s10456-026-10092-2

Image Credits: AI Generated

DOI: 10.1007/s10456-026-10092-2

Keywords: RORα, age-related macular degeneration, choroidal neovascularization, macrophages, microglia, PPARγ, lipid accumulation, inflammation, nuclear receptor, retina, drusen, NF-κB

The research team began by examining peripheral blood from healthy human volunteers, stratified into young adults aged 18 to 40 and middle-aged adults aged 41 to 65. When natural killer cells were stimulated in the laboratory with the cytokine interleukin-15, a potent activator of NK cell activity, a striking sex-specific pattern emerged. Cells from middle-aged men expressed significantly lower levels of CD107a, a marker of degranulation that reflects the cell’s ability to release its cytotoxic payload, and produced markedly less interferon-gamma, the signature cytokine that coordinates antiviral and antitumor responses. In contrast, natural killer cells from middle-aged women performed comparably to those from young women across these functional readouts. Enzyme-linked immunosorbent assays of purified CD3-negative CD56-positive cells confirmed that the cytokine secretion deficit in middle-aged men was genuine and not an artifact of intracellular staining.

Surface receptor profiling added further nuance. The investigators measured a panel of receptors known to regulate natural killer cell development and function, including CD150, 2B4, CD84, CD319, NKG2A, NKG2D, CD48, Ly9, Ly108, Tim-3, and CD69. Most of these were unchanged between age groups, but young male donors displayed higher expression of CD48, a ligand involved in activating signals. The authors conclude that reduced cytotoxic function and diminished cytokine production are defining characteristics of natural killer cells in middle-aged men, even in the absence of overt disease.

To dissect the mechanisms behind this human observation, the team turned to a mouse model, comparing 8-week-old young males with 48-week-old middle-aged animals, an age that corresponds roughly to human midlife. Consistent with prior work, the middle-aged mice were substantially heavier, with magnetic resonance imaging revealing elevated fat mass and enlarged epididymal and inguinal white adipose depots. Brown adipose tissue also increased in mass, but its thermogenic browning capacity was significantly diminished. Metabolic cage experiments painted a coherent picture of midlife metabolic decline: oxygen consumption, carbon dioxide production, respiratory exchange ratio, and whole-body energy expenditure all fell significantly, even though spontaneous activity levels were comparable between age groups. Food and water intake were actually reduced, underscoring that the adiposity of middle age reflects a fundamental shift in basal metabolism rather than simple overconsumption.

Flow cytometric analysis across the spleen, bone marrow, liver, peripheral blood, and adipose tissues revealed that natural killer cells were among the most affected immune populations. The relative proportion of NK cells dropped significantly in the spleen and liver, and within adipose tissue the percentage fell in epididymal white adipose tissue, with numbers per gram of tissue reduced across all three fat depots. Maturation, tracked using the classical CD27 and CD11b staging scheme, was also impaired. Middle-aged mice showed an accumulation of immature CD27-positive single-positive cells and a loss of mature CD11b-positive single-positive cells in the spleen and bone marrow, a pattern resembling that previously described in much older animals. In the fat depots, mature subsets were similarly depleted. Notably, the liver appeared relatively spared, suggesting tissue-specific vulnerability. Broader immune profiling using t-distributed stochastic neighbor embedding showed that other lymphocyte populations were largely unchanged, with the notable exception of increased M1 and M2 macrophages in the spleen, reinforcing that natural killer cells represent a particularly sensitive target of the midlife immune environment.

The receptor landscape of natural killer cells shifted in ways that would be expected to blunt surveillance. In the spleen, the inhibitory receptors KLRG1 and TIGIT were downregulated while Ly49A was upregulated, and the activation marker CD69 along with the immature markers CD117 and CD127 were elevated, consistent with a less differentiated, functionally compromised state. Adipose tissue NK cells displayed their own distinctive receptor changes, with broad upregulation of multiple activating and inhibitory receptors in epididymal fat. Survival analysis helped explain the falling cell counts: splenic natural killer cells from middle-aged mice showed increased Annexin V positivity, indicating heightened apoptosis, alongside reduced Ki-67 expression, a marker of proliferation. Proliferation was also reduced in bone marrow, epididymal fat, and brown fat. Single-cell RNA sequencing of splenic and bone marrow NK cells reinforced the functional picture, revealing downregulation of NK cell activation pathways and upregulation of p53-mediated signaling in middle-aged animals.

Function followed form. When splenocytes or bone marrow cells were challenged ex vivo with MHC class I-deficient target cells such as YAC-1 and RMA-S, natural killer cells from middle-aged mice produced significantly less interferon-gamma and expressed less surface CD107a than those from young controls. The deficit extended deep into the adipose tissue microenvironment: NK cells isolated from epididymal, inguinal, and even brown fat depots showed markedly impaired degranulation and cytokine production. Imaging flow cytometry using the neutral lipid dye Bodipy 493/503 provided a possible mechanistic clue. Natural killer cells from middle-aged mice accumulated more intracellular lipid than those from young mice, with the most pronounced lipid burden observed in cells residing in epididymal white adipose tissue. This finding echoes earlier reports that lipid droplet accumulation inside NK cells can compromise their cytotoxic machinery, and it suggests that a lipid-enriched adipose microenvironment may directly poison the antitumor capacity of these lymphocytes.

To separate the effects of aging from those of obesity itself, the researchers fed 8-week-old young male mice a high-fat diet deriving 60 percent of calories from fat for 16 weeks. These diet-induced obese animals, though young, mirrored many of the NK cell defects seen in their middle-aged counterparts. Splenic and bone marrow natural killer cells showed reduced interferon-gamma production and degranulation upon target cell stimulation, and cells within all three adipose depots displayed the same functional impairment. The authors note that NK cell dysfunction was, if anything, more pronounced in the high-fat diet group than in middle-aged mice, likely because the dietary model produced even greater adipose expansion. Together with previous reports that dietary restriction can enhance NK cell function, this experiment supports the interpretation that excess adiposity itself, independent of chronological age, is a major driver of the immune decline observed in midlife.

The study has limitations that the authors acknowledge. The comparison between middle-aged obesity and diet-induced obesity is indirect and cannot fully disentangle the two conditions, and the focus on male participants and male mice, justified by the far more pronounced weight gain and adipogenesis seen in males during middle age, leaves sex-specific differences in female biology largely unexplored. Nevertheless, the implications are considerable. Epidemiological data indicate that middle-aged adults with obesity face a higher mortality risk than expected for their conditions, and the loss of natural killer cell quantity and surveillance documented here offers a plausible immunological mechanism linking midlife weight gain to increased vulnerability against cancer and infections. Because white adipose tissue is the first organ to show age-related transcriptomic changes beginning in middle age, and because longevity-promoting pathways such as sirtuins and forkhead box proteins typically suppress adipogenesis, the study positions the expanding fat depot not merely as a passive energy store but as an active remodeler of systemic immunity. If confirmed in larger and more diverse cohorts, these findings suggest that maintaining metabolic health through the middle decades could help preserve the innate immune defenses that guard the body against malignancy and viral disease well before old age arrives.

Subject of Research: Natural killer cell dysfunction during midlife obesity in humans and mice

Article Title: Natural Killer Cell Dysfunction Is Emerging During Midlife Obesity

Article References: Biao, R., Wang, X., Fu, J., Guo, Y., He, J., & Du, J. (2026). Natural Killer Cell Dysfunction Is Emerging During Midlife Obesity. Aging Cell, 25(9), Article e70707. https://doi.org/10.1111/acel.70707

Image Credits: AI Generated

DOI: 10.1111/acel.70707

Keywords: natural killer cells, midlife obesity, immune aging, white adipose tissue, interferon-gamma, lipid accumulation, inflammaging, high-fat diet, basal metabolic rate, NK cell maturation, cytotoxicity, Aging Cell